Group 1 - The core action in the humanoid robot sector is the acquisition by UBTECH (9880.HK) of a 43% stake in Fenglong Co., Ltd. (002931.SZ) for 1.665 billion yuan, marking a significant step in UBTECH's "H+A" dual capital platform strategy [2] - The share transfer and tender offer price is set at 17.72 yuan per share, reflecting a 10% discount from Fenglong's last closing price of 19.68 yuan before suspension [2] - Following the announcement, Fenglong's stock surged to a limit-up of 21.65 yuan per share upon resuming trading, increasing its market capitalization to 4.7 billion yuan [2] Group 2 - Fenglong's business focus on garden machinery parts, automotive components, and hydraulic parts complements UBTECH's needs for extending its industrial chain [4] - UBTECH has no immediate plans to alter Fenglong's main business or make significant adjustments within the next 12 months [4] - The acquisition aligns with UBTECH's capital strategy and industrial implementation, aiming to leverage multi-tiered capital market synergies for global expansion and resource enhancement [4] Group 3 - UBTECH's humanoid robot Walker S2 has seen significant market expansion, including a strategic partnership with Texas Instruments and a project win in Huizhou worth nearly 60 million yuan [5] - Current monthly production capacity for Walker S2 exceeds 300 units, with an expected annual delivery of over 500 units, and a projected capacity increase to 10,000 units by 2026 [5] - The humanoid robot industry is experiencing a dual drive of industrialization and capitalization, with leading companies pursuing mergers and IPOs to accelerate their capital processes [5]

本文字数：1021，阅读时长大约2分钟 作者 |第一财经 乔心怡 人形机器人，或将迎来"H+A第一股"。 优必选（9880.HK）发布公告，以"协议转让+要约收购"的组合方式共收购深交所上市公司锋龙股份 （002931.SZ）93957518股，占锋龙股份公司股份总数43%。本次交易完成后，锋龙股份控股股东将由 诚锋投资变更为优必选，实际控制人由董剑刚变更为优必选创始人、董事会主席周剑。 2025.12.25 优必选在上市后就曾表示 "会积极关注并考虑包括在A股上市的各类可能性"。中关村物联网产业联盟副 秘书长袁帅告诉第一财经记者，优必选此次收购或意在借助多层次资本市场的协同效应，为企业全球化 布局和产业链延伸提供更多资源支持。 今年下半年以来，优必选在产业端的订单进展明显加快。12月中旬，美国德州仪器与优必选正式达成战 略合作，德州仪器已采购优必选的工业人形机器人Walker S2，并正在其生产线上进行部署和调试。此 后，优必选中标惠州市惠阳区人形机器人大湾区数据采集中心项目，金额达5962.015万元，中标产品全 部为优必选工业人形机器人Walker S2。 产能方面，根据优必选披露，Walker S2当 ...

Core Viewpoint - The article discusses the acquisition of a controlling stake in Fenglong Co., Ltd. by UBTECH Robotics, marking a significant step towards the company's exploration of the "H+A" (Human + AI) path in the humanoid robot industry [3][7]. Group 1: Acquisition Details - UBTECH Robotics announced the acquisition of 93,957,518 shares of Fenglong Co., Ltd., representing 43% of the total shares, through a combination of agreement transfer and tender offer [3]. - The share transfer and tender offer price is set at 17.72 CNY per share, which is a 10% discount compared to the last trading price of 19.68 CNY before the suspension [3]. - The total consideration for the acquisition amounts to 1.665 billion CNY [3]. Group 2: Market Reaction and Company Overview - Following the announcement, Fenglong Co., Ltd. opened with a limit-up at 21.65 CNY per share, giving it a market capitalization of 4.7 billion CNY [4]. - UBTECH Robotics has no immediate plans to change the main business operations of Fenglong Co., Ltd. within the next 12 months [4]. Group 3: Business Developments - In the second half of the year, UBTECH has accelerated its order progress, including a strategic partnership with Texas Instruments for the deployment of its Walker S2 industrial humanoid robot [6]. - UBTECH won a project in Huizhou, with a contract value of 59.62 million CNY for the supply of Walker S2 robots [6]. - The current monthly production capacity of the Walker S2 exceeds 300 units, with an expected annual delivery of over 500 units, and a projected capacity increase to 10,000 units by 2026 [6]. Group 4: Future Challenges - The acquisition is seen as a crucial step for UBTECH in exploring the "H+A" path, but long-term success will depend on the company's ability to maintain delivery schedules, cost control, and stability in its industrial humanoid robots [7]. - The alignment between capital market narratives and actual engineering capabilities will significantly impact the value of UBTECH's "H+A" strategy [7].

从长期来看，真正的挑战仍在于工业人形机器人能否在交付节奏、成本控制和稳定性上持续兑现预期。 人形机器人，或将迎来"H+A第一股"。 优必选（9880.HK）发布公告，以"协议转让+要约收购"的组合方式共收购深交所上市公司锋龙股份（002931.SZ）93957518股，占锋龙股份公司股份总数 43%。本次交易完成后，锋龙股份控股股东将由诚锋投资变更为优必选，实际控制人由董剑刚变更为优必选创始人、董事会主席周剑。 根据公告，本次控制权变更方案中的股份转让价格、要约收购价格均为17.72元/股，该价格相比12月17日锋龙股份停牌前19.68元/股折让10%，以此计算，合 计总对价达16.65亿元。 12月25日，锋龙股份开盘一字涨停，报21.65元/股，市值47亿元。截至上一个交易日收盘，优必选报价109.5港元/股。据介绍，锋龙股份核心业务为园林机 械零部件、汽车零部件及液压零部件的研发、生产与销售，产品涵盖点火器、飞轮、汽缸及精密铝压铸零部件等关键组件。根据公告，优必选暂无在未来12 个月内改变锋龙股份主营业务或者对上市公司主营业务做出重大调整的明确计划。 优必选在上市后就曾表示 "会积极关注并考虑包括在A股 ...

锁定控制权 12月24日晚间，港股上市公司优必选（9880.HK）与A股上市公司锋龙股份（002931.SZ）联合发布公 告，优必选拟通过"协议转让+要约收购"的组合方式，合计斥资约16.65亿元人民币，收购锋龙股份约 43%的股份。 交易完成后，优必选将取得锋龙股份的控制权，锋龙股份控股股东将变更为优必选，实际控制人将由董 剑刚变更为优必选创始人周剑。锋龙股份股票将于12月25日开市起复牌。 根据公告披露的交易方案，本次收购分三步进行。首先，优必选与诚锋投资等卖方签署《股份转让协 议》，以现金方式受让锋龙股份29.99%的股份。其次，在股份转让完成后，优必选将向除转让方以外 的股东发出部分要约，计划收购13.02%的股份。最后，原控股股东诚锋投资及其一致行动人承诺预受 要约，并放弃剩余股份的表决权 。 在价格方面，本次股份转让价格与要约收购价格均为17.72元/股。该价格较锋龙股份停牌前最后一个交 易日（12月17日）的收盘价19.68元/股折价约10%。本次收购所需资金总额约16.65亿元，优必选表示将 使用内部资源（包括此前配售H股所得款项）进行支付。 对于此次收购的目的，优必选在公告中表示，旨在通过整 ...

Core Viewpoint - UBTECH Robotics, known as the "first humanoid robot stock," plans to acquire a total of 93.95 million shares of Fenglong Co., accounting for 43% of its total share capital, through a combination of "agreement transfer + tender offer," with a total consideration of 1.665 billion yuan [1][2]. Group 1: Acquisition Details - On December 24, 2023, Fenglong's controlling shareholder, Chengfeng Investment, signed an agreement with UBTECH to transfer 65.53 million unrestricted circulating shares, representing 29.99% of the total share capital, at a price of 17.72 yuan per share, totaling 1.161 billion yuan [1][2]. - After the share transfer registration is completed, UBTECH will issue a partial tender offer to all shareholders of Fenglong, with a total of 28.45 million shares (13.02% of total share capital) at the same price of 17.72 yuan per share, amounting to 500 million yuan [2]. Group 2: Shareholding and Control Changes - Following the share transfer and the waiver of voting rights, UBTECH will hold 29.99% of Fenglong's shares and corresponding voting rights, changing the controlling shareholder from Chengfeng Investment to UBTECH, and the actual controller from Dong Jiangang to Zhou Jiang [2][3]. - Upon completion of the tender offer, UBTECH may hold a total of 93.98 million shares, approximately 43.01% of the total shares after excluding shares in the repurchase account [2]. Group 3: Company Background and Financial Performance - Fenglong Co., established in June 2003, specializes in the research, production, and sales of garden machinery engines, electric machines, hydraulic control systems, and automotive parts, with applications in various garden machinery and industrial sectors [4][5]. - In the first three quarters of 2025, Fenglong reported revenue of 373 million yuan, a year-on-year increase of 9.47%, and a net profit of 21.52 million yuan, a significant year-on-year increase of 1714.99% [5]. - UBTECH, founded in March 2012, focuses on humanoid robotics technology and has been involved in the development and commercialization of intelligent service robot solutions across various industries. In the first half of 2025, UBTECH reported revenue of 621 million yuan, a year-on-year increase of 27.55%, with a loss of 440 million yuan, which has narrowed compared to the previous year [5].

Group 1 - Guangqi Technology's controlling shareholder proposed a share buyback of 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] - Xingyuan Zhuomai received a supplier designation from a domestic electric vehicle manufacturer to develop and supply reducer shell components, with expected sales of approximately 575 million yuan over four years from 2027 to 2030 [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Hongda Electronics disclosed uncertainty regarding the IPO progress of its associate Jiangsu Zhanxin, in which it holds a 13.79% stake [4] - Kangchen Pharmaceutical received FDA approval to conduct clinical trials for its KC1086 project, aimed at treating advanced recurrent or metastatic solid tumors [5] - Kweichow Moutai adjusted its share buyback price ceiling to 1863.67 yuan per share, effective from December 19, 2025 [6] Group 3 - Mousse Co. announced that its controlling shareholder and actual controllers committed not to reduce their holdings within one year [7] - Tongxingbao's subsidiary signed a business contract worth 43.166 million yuan for a cloud expansion project [8] - Kaifa Electric announced plans for three shareholders to collectively reduce their holdings by 0.6999% [9] Group 4 - Longpan Technology plans to increase the production capacity of lithium iron phosphate cathode materials from 62,500 tons per year to 100,000 tons per year [10] - Zhuhai Guanyu announced plans for two shareholders to reduce their holdings by up to 3% [11] - Jiaheng Home Textiles is planning a change in control, leading to a temporary suspension of its stock [12] Group 5 - Kehua Bio's subsidiary received a medical device registration certificate for a gene polymorphism detection kit [13] - Saitex New Materials' actual controller plans to reduce holdings by up to 3% [14] - Sanhui Electric announced a shareholder's plan to reduce holdings by up to 2% [15] Group 6 - Binhua Co. plans to establish a venture capital fund with a total scale of 400 million yuan, focusing on strategic emerging industries [16] - Jindun Co. announced plans for two shareholders to reduce their holdings by up to 4% [17] - Hengdian East Magnetic's controlling shareholder plans to reduce holdings by up to 1% [18][19] Group 7 - Luxin Investment's controlling shareholder plans to reduce holdings by up to 1% [20] - Huakang Clean announced a joint bid for a hospital procurement project worth 157 million yuan [21] - Xuedilong plans to reduce its repurchased shares by up to 488,560 shares [22] Group 8 - Enhua Pharmaceutical's subsidiary signed an exclusive commercial cooperation agreement for three long-acting antipsychotic products [23] - Aier Eye Hospital plans to acquire partial equity in 39 institutions for a total of 963 million yuan [24] - Gaozheng Mining plans to acquire 100% equity of Overseas Explosives for 510 million yuan [25] Group 9 - Donghong Co. plans to repurchase shares worth 30 million to 60 million yuan for employee stock ownership plans [26] - Bear Electric's controlling shareholder plans to reduce holdings by up to 0.64% [27] - *ST Zhengping announced the initiation of pre-restructuring by the Xining Intermediate Court [28][29] Group 10 - Caesar Travel's shareholder plans to reduce holdings by up to 3% [30] - Lianchuang Electronics announced a change in controlling shareholder to Jiangxi State-owned Assets Supervision and Administration Commission [31] - Beixin Road and Bridge plans to transfer 5.33% equity in Henan Yuhang for 243 million yuan [32] Group 11 - Fenglong Co. is planning a change in control, with stock resuming trading [33]

Group 1 - The core point of the news is that UBTECH plans to acquire a controlling stake in Fenglong Co., Ltd. through a combination of agreement transfer and tender offer, totaling 93.96 million shares, which represents 43% of the company's total shares [1] - The share transfer price and tender offer price are both set at 17.72 RMB per share, reflecting a 10% discount compared to the last closing price of 19.68 RMB before the suspension on December 17 [1] - The total consideration for the acquisition amounts to 1.665 billion RMB [1] Group 2 - Fenglong Co., Ltd. announced that on December 24, an agreement was signed for the transfer of 65.53 million unrestricted circulating shares, accounting for 29.99% of the total share capital, from Chengfeng Investment to UBTECH at a price of 17.72 RMB per share, totaling 1.161 billion RMB [2] - Following the completion of the share transfer registration, UBTECH will issue a partial tender offer to all shareholders, with the number of shares to be acquired amounting to 28.45 million, representing 13.02% of the total share capital [2] - After the transaction is completed, the controlling shareholder will change from Chengfeng Investment to UBTECH, and the actual controller will change from Dong Jianggang to Zhou Jian [2]

| | 复权 叠加 多股 统计 | 画线 标记 +自选 返回 | | | 锋龙股份福建002931 | | 通用机械 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 22.37 | | 22.50 | | 21.65 1.97 10.01% | | 0.30% | | | | | 21.00 | 米 | 英 | 撒 | all | | | | | 19.50 | 家 | | | | | | | | 18.00 | में ब | | | | | | | | 16.50 | 卖二 | | | | | | | | 15.00 | 英 | | | | | | | | | | | 21.65 4598915 | | | 财 | 跌 榜 | 停 | | | 21.64 | 20027 | | | | A.I.III... IIIII. | | 10.00 | | 21.63 | 972 376 129 | | | | | | | | 21.62 | | | | | | | | 深 | 21.61 | | | | | | | | 涨停 | 21.65 | 跌 ...

（原标题：优必选拟入主，002931，"一字"涨停，开盘封单量两倍于流通盘） 锋龙股份(002931)今日复牌后一字涨停，开盘涨停板封单量达459.89万手，两倍于流通盘，之后封单量有所减少。 12月24日晚间，锋龙股份发布筹划控制权变更的相关公告，有"人形机器人第一股"之称的优必选将入主。 根据锋龙股份公告，公司控股股东诚锋投资及其一致行动人董剑刚、锋驰投资、厉彩霞与深圳市优必选科技股份有限公司（简称"优必选"）签署 协议，约定诚锋投资向优必选协议转让公司6552.99万股无限售条件流通股股份（占公司总股本的29.99%）及其所对应的所有股东权利和权益，每 股转让价格17.72元，价款总额11.61亿元。 食品饮料ETF (产品代码: 515170) ★ 跟踪：中证细分食品饮料产业主题指数 近五日涨跌:0.00% 市盈率: 20.10倍 资金流向: 最新份额为107.5亿份, 减 少了1.3亿份，净申 赎-7804.3万元。 本次股份转让过户登记完成后，优必选及/或其指定主体将向公司除受让方以外的全体股东发出部分要约收购，要约收购股份数量为2845万股（占 公司总股本的13.02%），价格为17.72元/股 ...